A detailed history of James Hambro & Partners transactions in Danaher Corp stock. As of the latest transaction made, James Hambro & Partners holds 281,897 shares of DHR stock, worth $65.7 Million. This represents 3.48% of its overall portfolio holdings.

Number of Shares
281,897
Previous 265,079 6.34%
Holding current value
$65.7 Million
Previous $66.2 Million 18.32%
% of portfolio
3.48%
Previous 3.27%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$239.25 - $280.76 $4.02 Million - $4.72 Million
16,818 Added 6.34%
281,897 $78.4 Million
Q2 2024

Jul 16, 2024

BUY
$235.51 - $267.98 $3.45 Million - $3.92 Million
14,636 Added 5.84%
265,079 $66.2 Million
Q1 2024

Apr 26, 2024

BUY
$224.58 - $256.19 $5.04 Million - $5.75 Million
22,438 Added 9.84%
250,443 $62.5 Million
Q4 2023

Jan 19, 2024

BUY
$185.1 - $233.13 $12.6 Million - $15.9 Million
68,290 Added 42.76%
228,005 $52.7 Million
Q3 2023

Oct 24, 2023

BUY
$233.08 - $265.59 $37 Million - $42.2 Million
158,842 Added 18194.96%
159,715 $39.6 Million
Q2 2023

Jul 20, 2023

SELL
$224.99 - $256.14 $43,873 - $49,947
-195 Reduced 18.26%
873 $209,000
Q1 2023

Apr 21, 2023

BUY
$239.75 - $277.0 $48,669 - $56,231
203 Added 23.47%
1,068 $269,000
Q2 2022

Jul 22, 2022

SELL
$237.11 - $299.66 $43,865 - $55,437
-185 Reduced 17.62%
865 $219,000
Q1 2022

May 05, 2022

SELL
$257.27 - $315.76 $578,600 - $710,144
-2,249 Reduced 68.17%
1,050 $308,000
Q4 2021

Feb 01, 2022

SELL
$292.08 - $329.01 $45,272 - $50,996
-155 Reduced 4.49%
3,299 $1.09 Million
Q1 2021

Apr 28, 2021

BUY
$212.38 - $245.9 $440,476 - $509,996
2,074 Added 150.29%
3,454 $778,000
Q4 2020

Jan 14, 2021

BUY
$212.5 - $245.46 $274,125 - $316,643
1,290 Added 1433.33%
1,380 $307,000
Q4 2017

Feb 13, 2018

BUY
$85.26 - $94.62 $7,673 - $8,515
90
90 $8,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track James Hambro & Partners Portfolio

Follow James Hambro & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Hambro & Partners, based on Form 13F filings with the SEC.

News

Stay updated on James Hambro & Partners with notifications on news.